pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
panobacumab
Aerumab (panobacumab [INN])
Hospital Acquired Pneumonia (HAP)
Aridis Pharmaceuticals Inc
0 catalysts
Marketed
parathyroid hormone
Natpara (parathyroid hormone)
Hypoparathyroidism
Takeda Pharmaceuticals America Inc
0 catalysts
Marketed
paricalcitol
Paricalcitol (paricalcitol)
Secondary Hyperparathyroidism
Marksans Pharma Inc
0 catalysts
Phase 3
← prev
page 204 of 231
next →
131
Pain89
Neurology1
paridiprubart
Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syn…
$EDSAEdesa Biotech, Inc.
0 catalysts
pre_registration
pariglasgene brecaparvovec
Glycogen Storage Disease 1A
$RAREUltragenyx Pharmaceutical Inc.
0 catalysts
Phase 3
paromomycin
Paromomycin Sulfate (paromomycin [INN])
Leishmaniasis
Appili Therapeutics Inc
0 catalysts
Marketed
paroxetine mesylate
Brisdelle (paroxetine mesylate)
Vasomotor Symptoms of Menopause (Hot Flashes)
Legacy Pharma Solutions
0 catalysts
Marketed
pasireotide
Signifor (pasireotide)
Pituitary ACTH Hypersecretion (Cushing Disease)
Recordati Corp
0 catalysts
Phase 3
pasritamig
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 3
patidegib hydrochloride
Gorlin Syndrome (Basal Cell Nevus Syndrome/ Nevoid Basal Cell Carcinoma Syndr…
$SLGLSol-Gel Technologies Ltd.
0 catalysts
Marketed
patiromer sorbitex calcium
Veltassa (patiromer sorbitex calcium)
Hyperkalemia
Vifor Pharma Inc
0 catalysts
Marketed
patisiran
Onpattro (patisiran)
Familial Amyloid Neuropathies
$ALNYALNYLAM PHARMACEUTICALS, INC.
0 catalysts
Phase 3
patritumab deruxtecan
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Receptor tyrosine-protein kinase erbB-3DNA topoisomerase 1
Daiichi Sankyo Co Ltd
0 catalysts
Phase 3
paxalisib
Recurrent Glioblastoma Multiforme (GBM)
PI3-kinase class I
$KZIAKAZIA THERAPEUTICS LTD
0 catalysts
Marketed
pazopanib hydrochloride
Pazopanib Hydrochloride (pazopanib hydrochloride)
Renal Cell Carcinoma
Novugen Pharma (Malaysia) Sdn Bhd
0 catalysts
Marketed
peanut (Arachis hypogaea) allergen
Palforzia
Peanut Allergy
Aimmune Therapeutics Inc
0 catalysts
Phase 2
peceleganan
peceleganan [INN]
Diabetic Foot Ulcers
Jiangsu ProteLight Pharmaceutical And Biotechnology Co Ltd
0 catalysts
pre_registration
pegargiminase
Malignant Pleural Mesothelioma
$PIIPolaris Inc.
0 catalysts
Marketed
pegaspargase
Oncaspar (pegaspargase)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Servier Pharmaceuticals LLC
0 catalysts
Phase 2
pegevongitide
pegevongitide [INN]
Coronavirus Disease 2019 (COVID-19) Pneumonia
Vasomune Therapeutics Inc
0 catalysts
Marketed
pegfilgrastim
Udenyca (pegfilgrastim-cbqv)
Febrile Neutropenia
Accord Biopharma Inc
0 catalysts
Preclinical
pegfilgrastim biosimilar
Fylnetra (pegfilgrastim-pbbk)
Unspecified Cancer
Meitheal Pharmaceuticals Inc
0 catalysts
Marketed
peginterferon alfa-2a
Pegasys (peginterferon alfa-2a)
Hepatitis B
pharmaand GmbH
0 catalysts
Marketed
peginterferon beta-1a
Plegridy (peginterferon beta-1a)
Progressive Relapsing Multiple Sclerosis (PRMS)
$BIIBBIOGEN INC.
0 catalysts
Phase 3
peginterferon lambda-1a
Coronavirus Disease 2019 (COVID-19)
Interferon lambda receptor
Eiger Inno Therapeutics Inc
0 catalysts
Marketed
pegloticase
Krystexxa (pegloticase)
Gouty Arthritis (Gout)
Horizon Therapeutics USA Inc
0 catalysts
Phase 1
pegmispotide
pegmispotide[INN]
Ulcerative Colitis
Adiso Therapeutics Inc
0 catalysts
Phase 3
pegozafermin
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
89bio Inc
0 catalysts
Phase 2
pegsebrenatide
pegsebrenatide [INN]
Multiple Sclerosis
Neuraly Inc
0 catalysts
Phase 2
pegtarazimod hydrochloride
Chronic Obstructive Pulmonary Disease (COPD)
ReAlta Life Sciences Inc
0 catalysts